🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as trastuzumab, can block tumor grow...
Status
Completed
Location
Kantonspital Aarau
Start Date
2005-05
Trial ID
NCT00238290
Treatments Being Tested
Observational investigation of participants who are given neoadjuvant treat...
Status
Not Yet Recruiting
Location
National Institute of Oncolgy
Start Date
2022-03
Trial ID
NCT05131893
AMBRE is a phase III study comparing two standard treatments as initial met...
Status
Active Not Recruiting
Location
Centre Hospitalier Lyon Sud
Start Date
2020-06-11
Trial ID
NCT04158362
The present multi-center, open-label, single-arm study aims to evaluate the...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-06
Trial ID
NCT01626222
Treatments Being Tested
The main purpose of this study is to learn more about the safety and tolera...
Status
Completed
Location
MNJ Institute of Oncology
Start Date
2021-02-22
Trial ID
NCT04707196
Treatments Being Tested
Given the uncertain benefit in efficacy of adding CDK 4/6 to first rather t...
Status
Active Not Recruiting
Location
Jeroen Bosch Ziekenhuis
Start Date
2017-11-09
Trial ID
NCT03425838
Treatments Being Tested
This was a randomized, double-blind, placebo-controlled study conducted in ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-08-29
Trial ID
NCT03671330
Treatments Being Tested
Observational, longitudinal (retrospective cohort), multicenter, national s...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-03-23
Trial ID
NCT05569187
Treatments Being Tested
The purpose of this study is to compare the efficacy of Faslodex (fulvestra...
Status
Completed
Location
Research Site
Start Date
2003-08
Trial ID
NCT00065325
Treatments Being Tested
Approximately 3.5% to 6% of newly diagnosed breast cancer patients are stag...
Status
Active Not Recruiting
Location
Institut de Cancérologie de l'Ouest-Site Paul Papin
Start Date
2019-10-23
Trial ID
NCT03870919
Treatments Being Tested